CO6351790A2 - Derivados de carbonato de quinuclidina y composicion medicinal de los mismos - Google Patents
Derivados de carbonato de quinuclidina y composicion medicinal de los mismosInfo
- Publication number
- CO6351790A2 CO6351790A2 CO11013721A CO11013721A CO6351790A2 CO 6351790 A2 CO6351790 A2 CO 6351790A2 CO 11013721 A CO11013721 A CO 11013721A CO 11013721 A CO11013721 A CO 11013721A CO 6351790 A2 CO6351790 A2 CO 6351790A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- optionally substituted
- nr2co
- formula
- group selected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención está dirigida a derivados de carbonato de quinuclidina de fórmula general (I)donde: A puede ser arilo o heteroarilo o arilalquilo o heteroarilalquilo o un grupo de fórmula (a) opcionalmente sustituidoDonde R3 y R4 son iguales o diferentes con la condición de que R3 y R4 nunca son ambos H.R es un residuo seleccionado entre:- (C1-C10)-alquilo, (C2-C10)-alquenilo y (C2-C10)-alquinilo opcionalmente sustituido con un grupo seleccionado entre:- un grupo seleccionado entre de NH2, NR1R2, CONR1R2, NR2COR1, OH, SOR1, SO2R1, SH, CN, NO2 ycompuestos alicíclicos;- Z-R1, donde Z se selecciona entre CO, O, COO, OCO, SO2, S, SO, COS y SCO o es una unión y- (C3-C8)-cicloalquilo.R1 es un residuo seleccionado entre:- compuesto alicíclico opcionalmente sustituido con uno o varios sustituyentes seleccionados independientemente entre OH, oxo (=O), SH, NO2, CN, CONH2, NR2CO-(C1-Cx)-aIquilo, COOH, (C1-C10)- alcoxicarbonilo, (C1-C10)-alquilsulfanilo, (C1-C10)-alquilsulfinilo, (C1-C10)alquilsulfonilo, (C1-C10)-alquilo y (C1-C10)-alcoxilo NR2CO-(C1-C10)- alquilo;- arilo opcionalmente sustituido con NR2CO-(C1-C10)-alquilo, (C1-C10)-alquilo, O-(C1-C10)-alquilo o halógeno y- heteroarilo opcionalmente sustituido con NR2CO-(C1-C10)-alquilo o halógeno.R2 es un grupo seleccionado entre H, fenoxicarbonilo, benciloxicarbonilo, (C1-C10)-alcoxicarbonilo, (C1-C10)-alquilcarbonilo, (C1-C10)-alquilsulfonilo y (C1-C10)-alquilo.X´ es un anión aceptable fisiológicamente.La presente invención también provee composiciones farmacéuticas de compuestos de fórmula (I) solos o en combinación con o en mezcla con uno o más vehículos y/o excipientes farmacéuticamente aceptables.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08162066A EP2154136A1 (en) | 2008-08-08 | 2008-08-08 | Quinuclidine carbonate derivatives and medicinal compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6351790A2 true CO6351790A2 (es) | 2011-12-20 |
Family
ID=40228074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO11013721A CO6351790A2 (es) | 2008-08-08 | 2011-02-07 | Derivados de carbonato de quinuclidina y composicion medicinal de los mismos |
Country Status (32)
| Country | Link |
|---|---|
| US (3) | US8039483B2 (es) |
| EP (2) | EP2154136A1 (es) |
| JP (1) | JP2011530489A (es) |
| KR (1) | KR20110044221A (es) |
| CN (1) | CN102112474B (es) |
| AR (1) | AR072994A1 (es) |
| AT (1) | ATE551341T1 (es) |
| AU (1) | AU2009278306B2 (es) |
| CA (1) | CA2733380A1 (es) |
| CO (1) | CO6351790A2 (es) |
| CY (1) | CY1112724T1 (es) |
| DK (1) | DK2313404T3 (es) |
| EA (1) | EA019166B1 (es) |
| ES (1) | ES2384914T3 (es) |
| GE (1) | GEP20135744B (es) |
| HK (1) | HK1156032A1 (es) |
| HR (1) | HRP20120394T1 (es) |
| IL (1) | IL211103A (es) |
| JO (1) | JO2831B1 (es) |
| MA (1) | MA32622B1 (es) |
| ME (1) | ME01283A (es) |
| MX (1) | MX2011001504A (es) |
| MY (1) | MY156332A (es) |
| NZ (1) | NZ590987A (es) |
| PL (1) | PL2313404T3 (es) |
| PT (1) | PT2313404E (es) |
| RS (1) | RS52370B (es) |
| SI (1) | SI2313404T1 (es) |
| TW (1) | TWI455938B (es) |
| UA (1) | UA102857C2 (es) |
| WO (1) | WO2010015324A1 (es) |
| ZA (1) | ZA201100963B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2394589T3 (es) | 2007-12-14 | 2013-02-04 | Aerodesigns, Inc | Suministro de productos alimenticios transformables en aerosol |
| EP2154136A1 (en) | 2008-08-08 | 2010-02-17 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine carbonate derivatives and medicinal compositions thereof |
| EP2206712A1 (en) | 2008-12-23 | 2010-07-14 | CHIESI FARMACEUTICI S.p.A. | "Alkaloid aminoester derivatives and medicinal composition thereof" |
| AU2011244384B2 (en) | 2010-04-21 | 2016-06-23 | Chiesi Farmaceutici S.P.A. | "Process for providing particles with reduced electrostatic charges" |
| KR20130087406A (ko) | 2010-06-22 | 2013-08-06 | 키에시 파르마슈티시 엣스. 피. 에이. | 알칼로이드 아미노에스테르 유도체 및 이의 의약 조성물 |
| KR20130087405A (ko) | 2010-06-22 | 2013-08-06 | 키에시 파르마슈티시 엣스. 피. 에이. | 알칼로이드 아미노에스테르 유도체 및 이의 의약 조성물 |
| ES2545812T3 (es) | 2010-06-22 | 2015-09-16 | Chiesi Farmaceutici S.P.A. | Derivados aminoéster de alcaloides y composición medicinal de estos |
| KR20140005150A (ko) * | 2010-09-30 | 2014-01-14 | 키에시 파르마슈티시 엣스. 피. 에이. | 흡입용 건조 분말 제제 내 마그네슘 스테아레이트의 용도 |
| RU2013118026A (ru) * | 2010-10-20 | 2014-10-27 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Карбонатные производные для лечения кашля |
| CN103221390B (zh) | 2010-11-26 | 2015-06-03 | 奇斯药制品公司 | 甘氨酸衍生物及其医药组合物 |
| UA118248C2 (uk) * | 2011-03-18 | 2018-12-26 | Джензім Корпорейшн | Інгібітори глюкозилцерамідсинтази |
| WO2012146515A1 (en) * | 2011-04-29 | 2012-11-01 | Chiesi Farmaceutici S.P.A. | Alkaloid ester and carbamate derivatives and medicinal compositions thereof |
| WO2013098145A1 (en) | 2011-12-30 | 2013-07-04 | Chiesi Farmaceutici S.P.A. | Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof |
| MA37975B2 (fr) * | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
| US9427376B2 (en) | 2013-10-10 | 2016-08-30 | Chiesi Farmaceutici S.P.A. | Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient |
| MX2022009477A (es) | 2020-02-03 | 2022-08-22 | Genzyme Corp | Metodos para el tratamiento de sintomas neurologicos asociados con las enfermedades de almacenamiento lisosomico. |
| CN116133647A (zh) | 2020-07-24 | 2023-05-16 | 建新公司 | 包含文鲁司他的药物组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| SI1345937T1 (sl) | 2000-12-22 | 2006-02-28 | Almirall Prodesfarma Ag | Derivati kinulidinkarbamata in njihova uporaba kot M3 antagonisti |
| WO2002096855A2 (en) * | 2001-04-03 | 2002-12-05 | Aryx Therapeutics | Anticholinergic compounds and methods of use |
| CA2470956C (en) | 2001-12-20 | 2011-08-02 | Laboratorios S.A.L.V.A.T., S.A. | 1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives and their use as muscarinic receptor antagonists |
| EP1882691A1 (en) * | 2006-07-26 | 2008-01-30 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine derivatives as M3 antagonists |
| EP2154136A1 (en) | 2008-08-08 | 2010-02-17 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine carbonate derivatives and medicinal compositions thereof |
| EP2206712A1 (en) | 2008-12-23 | 2010-07-14 | CHIESI FARMACEUTICI S.p.A. | "Alkaloid aminoester derivatives and medicinal composition thereof" |
| NZ604983A (en) | 2010-06-22 | 2014-07-25 | Chiesi Farma Spa | Dry powder formulation comprising an antimuscarinic drug |
| RU2013118026A (ru) | 2010-10-20 | 2014-10-27 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Карбонатные производные для лечения кашля |
| US20120220557A1 (en) | 2011-02-17 | 2012-08-30 | Chiesi Farmaceutici S.P.A. | Liquid propellant-free formulation comprising an antimuscarinic drug |
| WO2012146515A1 (en) | 2011-04-29 | 2012-11-01 | Chiesi Farmaceutici S.P.A. | Alkaloid ester and carbamate derivatives and medicinal compositions thereof |
-
2008
- 2008-08-08 EP EP08162066A patent/EP2154136A1/en not_active Withdrawn
-
2009
- 2009-07-21 MX MX2011001504A patent/MX2011001504A/es active IP Right Grant
- 2009-07-21 EP EP09777321A patent/EP2313404B1/en active Active
- 2009-07-21 JP JP2011521454A patent/JP2011530489A/ja active Pending
- 2009-07-21 MY MYPI2011000542A patent/MY156332A/en unknown
- 2009-07-21 ME MEP-2011-24A patent/ME01283A/me unknown
- 2009-07-21 SI SI200930266T patent/SI2313404T1/sl unknown
- 2009-07-21 NZ NZ590987A patent/NZ590987A/xx not_active IP Right Cessation
- 2009-07-21 UA UAA201101383A patent/UA102857C2/ru unknown
- 2009-07-21 EA EA201100161A patent/EA019166B1/ru not_active IP Right Cessation
- 2009-07-21 CN CN200980130187.4A patent/CN102112474B/zh active Active
- 2009-07-21 ES ES09777321T patent/ES2384914T3/es active Active
- 2009-07-21 PL PL09777321T patent/PL2313404T3/pl unknown
- 2009-07-21 RS RS20120262A patent/RS52370B/en unknown
- 2009-07-21 AU AU2009278306A patent/AU2009278306B2/en not_active Ceased
- 2009-07-21 AT AT09777321T patent/ATE551341T1/de active
- 2009-07-21 KR KR1020117002974A patent/KR20110044221A/ko not_active Application Discontinuation
- 2009-07-21 PT PT09777321T patent/PT2313404E/pt unknown
- 2009-07-21 WO PCT/EP2009/005272 patent/WO2010015324A1/en active Application Filing
- 2009-07-21 CA CA2733380A patent/CA2733380A1/en not_active Abandoned
- 2009-07-21 GE GEAP200912093A patent/GEP20135744B/en unknown
- 2009-07-21 DK DK09777321.2T patent/DK2313404T3/da active
- 2009-07-30 US US12/512,262 patent/US8039483B2/en active Active
- 2009-08-06 JO JO2009296A patent/JO2831B1/en active
- 2009-08-06 TW TW098126682A patent/TWI455938B/zh not_active IP Right Cessation
- 2009-08-07 AR ARP090103053A patent/AR072994A1/es unknown
-
2011
- 2011-02-07 IL IL211103A patent/IL211103A/en not_active IP Right Cessation
- 2011-02-07 CO CO11013721A patent/CO6351790A2/es active IP Right Grant
- 2011-02-07 ZA ZA2011/00963A patent/ZA201100963B/en unknown
- 2011-03-08 MA MA33683A patent/MA32622B1/fr unknown
- 2011-08-26 US US13/219,109 patent/US8440690B2/en active Active
- 2011-09-14 US US13/232,415 patent/US8404712B2/en active Active
- 2011-10-03 HK HK11110402.8A patent/HK1156032A1/xx not_active IP Right Cessation
-
2012
- 2012-05-10 HR HRP20120394AT patent/HRP20120394T1/hr unknown
- 2012-05-11 CY CY20121100443T patent/CY1112724T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6351790A2 (es) | Derivados de carbonato de quinuclidina y composicion medicinal de los mismos | |
| MX2009004910A (es) | Compuestos sustituidos de 3-isobutil-9,10-dimetoxi-1,3,4,6,7,11-b- hexahidro-2h-pirido[2,1-a] isoquinolin-2-ol y métodos que se relacionan al mismo. | |
| MX2007004699A (es) | Derivados de indol y bencimidazol. | |
| ME02558B (me) | Inhibitori replikacije virusa gripa | |
| WO2008065500A3 (en) | Heteroaryl amides as type i glycine transport inhibitors | |
| IL160769A (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| DOP2002000392A (es) | Sales tartrato de 5,8,14 triazatetraciclo [10.3.1.024 0.4.9] hexadeca-2 (11), 3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas | |
| MY148988A (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
| RU2012100913A (ru) | ПРОТИВООПУХОЛЕВЫЕ КОМБИНАЦИИ С ИНГИБИТОРАМИ mTOR, ГЕРЦЕПТИНОМ И/ИЛИ HKI-272 | |
| CA2545427A1 (en) | Selective kinase inhibitors | |
| WO2006039668B1 (en) | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection | |
| MY139571A (en) | Indolyl derivatives as liver-x-receptor modulators | |
| MX2010008101A (es) | Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica. | |
| EA201201052A1 (ru) | Замещенные нафтиридины и их применение в качестве ингибиторов киназы syk | |
| GEP20156209B (en) | Linaclotide-containing formulations for oral administration | |
| AR076008A1 (es) | Derivados de hidroximetil-isoxazol moduladores de receptores gaba a, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos para el tratamiento del alzheimer y otros trastornos cognitivos. | |
| EA201201414A1 (ru) | КОМБИНАЦИИ, СОДЕРЖАЩИЕ ЗАМЕЩЕННЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНЫ | |
| EA200601178A1 (ru) | Морфолинилсодержащие бензимидазолы в качестве ингибиторов репликации респираторно-синцитиального вируса | |
| AR079957A1 (es) | Derivados de acidos grasos de salicilatos composiciones farmaceuticas y uso de los mismos | |
| TW200630364A (en) | 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| UY27980A1 (es) | Indoles 2,7-sustituidos | |
| BR0312798A (pt) | Derivados de isotiazol úteis como agentes anticancerìgenos | |
| EA201171429A1 (ru) | Противораковое соединение и содержащая его фармацевтическая композиция | |
| AR033399A1 (es) | Malonamida y derivados del ester malonamico con actividad antitrombotica, un proceso para su preparacion y composicion farmaceutica | |
| RU2013149416A (ru) | Производные камптотецина, обладающие противоопухолевой активностью |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted |